Introduction/Overview
Pancreatic cancer, especially pancreatic ductal adenocarcinoma, is known as the "king of cancer" because of its insidious onset, rapid progress, high early metastasis rate and resistance to conventional chemotherapy and radiotherapy. The five-year survival rate of patients is extremely low. Therefore, the development of new, efficient and low toxicity anti pancreatic cancer drugs is an urgent need in the field of tumor treatment. Natural products have always been an important source of innovative drug discovery due to their structural diversity and rich biological activity. Sophoridine, a quinoxaline alkaloid isolated from the traditional Chinese medicine Sophora flavescens, has attracted much attention in recent years because of its remarkable anti-tumor activity in a variety of malignant tumors, especially pancreatic cancer. A large number of preclinical studies have shown that sophoridine can not only effectively inhibit tumor cell proliferation and induce apoptosis, but also show good selectivity and tolerance, making it a potential candidate drug for pancreatic cancer. This article aims to systematically review the chemical properties, plant sources, pharmacological activities, molecular mechanisms of action, pharmacological evaluation, and clinical application prospects of sophocarpine, in order to provide comprehensive scientific references for the in-depth research and development of this compound.
Chemical structure and physicochemical properties
The chemical name of sophocarpine is (13 α, 14 α) -5,6,7,8,13,14-hexahydro-13-methyl-7,14-methyl-6H-dibenzo [a, g] quinoxaline, and its CAS number is 6882-68-4. Structurally, sophocarpine belongs to the tetracyclic quinoxaline alkaloid family. Its core skeleton consists of two benzene rings (A and D) fused with one piperazine ring (B) and one nitrogen-containing ten membered bridging ring (C), forming a rigid "cage like" three-dimensional structure. This unique fused ring structure is an important material basis for its biological activity.
Its molecular formula is C15H24N2O and its molecular weight is 248.3700. From the analysis of parameters related to drug properties, sophocarpine exhibits ideal physicochemical properties. Its lipid water partition coefficient (LogP) is 1.5641, indicating that the compound has moderate lipophilicity, which is beneficial for its penetration into cell membranes. The topologically polar surface area (TPSA) is relatively low, at 23.5500 Å ², which is typically associated with good membrane permeability. The water solubility data is 8.7445 mg/L, which belongs to the range of slightly soluble to poorly soluble. This suggests that in the development of formulations, it may be necessary to improve their solubility through methods such as salt formation or the use of solubilizers. More importantly, the prediction shows that sophocarpine has a high blood-brain barrier permeability, which provides the possibility for its potential application in central nervous system related tumors or diseases. In early safety screening, sophoridine did not show significant hERG potassium channel inhibitory activity (predicted as' no '), reducing the risk of inducing QT interval prolongation and apical torsion ventricular tachycardia. The Ames test result is 0.6, indicating a low risk of mutagenicity. These physicochemical and early safety mass spectrometry have laid a favorable foundation for its further drug development.
Plant sources and extraction methods
Huaiding alkaloid mainly comes from the leguminous plant Sophora flavescens（Sophora flavescens Dry roots of Ait. Sophora flavescens, as a traditional Chinese medicinal herb, has a long history and is recorded in the "Shennong Bencao Jing". It has the effects of clearing heat and dampness, killing insects, and diuresis. Modern research has shown that it is rich in various alkaloids and flavonoids, among which alkaloids are its main active ingredient group.
The extraction and separation of sophocarpine from Sophora flavescens usually follow the conventional process of natural product chemistry. Firstly, the roots of Sophora flavescens are dried and crushed, and then extracted or refluxed with appropriate solvents (such as ethanol, methanol, or acidic aqueous solution) to obtain the crude extract of total alkaloids. Subsequently, utilizing the characteristics of alkaloids, the acid water extraction alkalization precipitation method is often used for preliminary enrichment: the crude extract is dissolved in dilute acid water, insoluble substances are filtered out, and lipophilic impurities are removed by organic solvent extraction (such as chloroform, dichloromethane); Then alkalize the acidic water layer to free the alkaloids and extract them with organic solvents to obtain the total alkaloids. Further purification relies on column chromatography technology, often using silica gel, alumina, or macroporous adsorption resin as the stationary phase, and gradient elution with different ratios of organic solvents (such as chloroform methanol, petroleum ether ethyl acetate, etc.). High performance liquid chromatography (HPLC) or preparative thin layer chromatography (PTLC) is commonly used for final monomer purification to obtain high-purity sophocarpine. With the development of technology, separation techniques such as high-speed countercurrent chromatography (HSCCC) that do not require solid carriers have also been applied to the efficient preparation and separation of sophocarpine due to their high recovery rate and avoidance of irreversible adsorption. The optimization of extraction processes, such as ultrasound assisted extraction and microwave-assisted extraction, also helps to improve extraction efficiency and save time.
Pharmacological activity research
The pharmacological activity research of sophocarpine has entered the stage of in-depth mechanism exploration for specific diseases from early broad-spectrum screening, and its anti-tumor activity is the core focus of research.
1. Anti pancreatic cancer activity: This is the most promising research direction for sophocarpine. In vivo and in vitro experiments have confirmed that sophoridine can significantly inhibit the proliferation of many pancreatic cancer cell lines (such as PANC-1, SW1990, BxPC-3) and induce apoptosis. In a nude mouse transplant tumor model, administration of sophoridine can significantly inhibit tumor growth and has lower toxicity than first-line chemotherapy drugs such as gemcitabine. Its effect is selective and has low toxicity to normal cells, indicating a wide therapeutic window.
2. Anti lung cancer activity: Based on the target information you provided, the study of sophoridine in lung cancer has also revealed its multi-target action characteristics. Research has shown that sophocarpine can inhibit lung cancer cell proliferation, promote apoptosis, and weaken its invasion and metastasis ability through various pathways, such as downregulating the expression of anti apoptotic protein BCL2, inhibiting the activation of transcription factors STAT3 and RELA (p65), and reducing the expression of matrix metalloproteinase MMP2. The regulation of targets such as ESR2 (estrogen receptor beta) and MAPT (microtubule associated protein tau) also suggests their potential in intervening in specific signaling pathways or phenotypes of lung cancer cells.
3. Other anti-tumor activities: In addition to pancreatic cancer and lung cancer, sophoridine also showed birth growth inhibition on gastric cancer, liver cancer, colorectal cancer, breast cancer, leukemia and other tumor cells, indicating that its anti-tumor spectrum is broad.
4. Anti inflammatory and immune regulatory activity: Sophora alkaloids have traditionally been used to treat inflammatory diseases. Huaiding alkaloid has been shown to inhibit the release of inflammatory factors induced by lipopolysaccharides (LPS), and its mechanism is closely related to the inhibition of the TLR4/NF - κ B signaling pathway. This corresponds to the observed inhibitory effect on inflammatory factors in the tumor microenvironment during its anti-tumor activity.
5. Cardiovascular and nervous system activity: Some studies have reported that sophocarpine has anti arrhythmic and protective effects against myocardial ischemia-reperfusion injury. Its high blood-brain barrier permeability also provides research clues for its application in neurological diseases such as Alzheimer's disease, which may be related to regulating MAPT.
Mechanism of action and molecular targets
The anti-tumor effect of sophocarpine is not achieved through a single target, but through networked regulation of multiple pathways and targets, which is in line with the characteristics of many natural products. According to existing research, its mechanism of action can be summarized as follows:
1. Inducing cell apoptosis: This is one of the core anti-tumor mechanisms of sophocarpine.
* Mitochondrial pathway: Huaiding alkaloid can downregulate the expression of anti apoptotic protein BCL2, disrupt the BCL2/BAX balance, lead to a decrease in mitochondrial membrane potential, release of cytochrome C, and activate caspase-9 and caspase-3, triggering a cascade apoptotic response.
* Death receptor pathway: Studies have shown that sophocarpine can upregulate the expression of death receptors (such as Fas), activate caspase-8, and thus initiate the exogenous apoptotic pathway.
* Endoplasmic reticulum stress pathway: Sophocarpine can induce endoplasmic reticulum stress, activate pathways such as CHOP and caspase-12, and participate in the induction of apoptosis.
2. Inhibit cell proliferation and cycle arrest: Huaiding alkaloid can block tumor cells in the G0/G1 or G2/M phase of the cell cycle, preventing them from entering the DNA synthesis or mitotic stage. This is related to its impact on the expression of cyclins, cyclin dependent kinases (CDKs), and their inhibitors such as p21. The target TOP2A (topoisomerase II α) is a key enzyme for DNA replication and cell division, and sophocarpine may affect the supercoiled state of DNA by interfering with its function, leading to cell cycle arrest and DNA damage.
3. Inhibit tumor invasion and metastasis: Huaiding alkaloid can significantly reduce the activity and expression of matrix metalloproteinases such as MMP2 and MMP9, thereby weakening the ability of tumor cells to degrade extracellular matrix and break through the basement membrane. Meanwhile, it can also upregulate the expression of tissue metalloproteinase inhibitors (TIMPs), further inhibiting the invasive phenotype.
4. Regulating key signaling pathways:
* PI3K/Akt/mTOR pathway: Huaiding alkaloid can inhibit the phosphorylation activation of PIK3CG (catalytic subunit γ of PI3K) and its downstream Akt and mTOR. This pathway is the core pathway that regulates cell survival, proliferation, and metabolism, and its inhibition is an important mechanism for sophocarpine induced apoptosis and growth inhibition.
* JAK/STAT3 pathway: STAT3 is an important oncogenic transcription factor. Huaiding alkaloid can inhibit the phosphorylation of JAK2 and STAT3, prevent STAT3 dimerization, nuclear translocation, and transcription of downstream target genes (such as BCL2, Cyclin D1, MMP2), thereby exerting anti proliferative and pro apoptotic effects.
* NF - κ B pathway: Huaiding alkaloid inhibits IKK complex activity or I κ B α degradation, prevents nuclear translocation of the key subunit RELA (p65) of NF - κ B, and downregulates the expression of inflammatory factors (such as TNF - α, IL-6) and anti apoptotic genes regulated by it. TLR4 is one of the upstream receptors that activate NF - κ B, and its inhibition by sophocarpine also plays a role in this pathway.
* Wnt/β - catenin pathway: In some tumors, sophocarpine has been shown to downregulate the expression and nuclear localization of β - catenin, and inhibit tumor development driven by abnormal activation of the Wnt pathway.
5. Impact on tumor microenvironment and immunity: By inhibiting pathways such as TLR4/NF - κ B, sophocarpine can reduce M2 polarization of tumor associated macrophages (TAMs) and secretion of inflammatory factors, improving the immunosuppressive microenvironment. The potential impact on ABCA1 (ATP binding cassette transporter A1) may involve cholesterol efflux and cell membrane lipid raft structure, the latter of which is associated with various signal transduction and drug efflux, but its specific role in the anti-tumor effect of sophocarpine remains to be elucidated.
6. Other potential mechanisms: The regulatory effects of sophocarpine on ESR2 and MAPT suggest that sophocarpine may have unique value in hormone sensitive tumors or neuroendocrine subtyping tumors, as well as diseases involving tau protein pathology, which are worthy of further exploration.
Evaluation of drug properties and pharmacokinetics
Although sophocarpine has shown good pharmacological activity, its successful conversion into clinical drugs depends on systematic pharmacological evaluation and pharmacokinetic studies.
Pharmacokinetic studies: Pharmacokinetic studies in animals have shown that sophocarpine is absorbed rapidly orally, but its absolute bioavailability may be limited due to first pass effects and other factors. It is widely distributed in the body, thanks to its moderate LogP and high blood-brain barrier permeability, and can achieve effective concentrations in multiple tissues, including tumor tissue and brain tissue. The metabolism of sophocarpine in the body mainly occurs in the liver, involving phase I metabolic reactions such as oxidation and demethylation, as well as possible phase II binding reactions. It is mainly excreted through the kidneys and urine. The existing data suggests that its elimination rate in the body is moderate and its half-life is appropriate, but the specific metabolic enzyme spectrum (such as CYP450 isoenzymes) and the main metabolites and their activities still need to be clarified.
Pharmaceutical research: To address the issue of poor water solubility of sophocarpine alkaloids, researchers have developed various novel delivery systems to enhance their bioavailability and targeting. For example, sophocarpine liposomes, sophocarpine nanoparticles, sophocarpine phospholipid complexes, sophocarpine cyclodextrin inclusion complexes, etc. These formulations can not only improve the solubility and stability of drugs, but also achieve targeted delivery to tumor sites by enhancing the permeation and retention (EPR) effect or active target modification, reducing systemic exposure and side effects.
Safety evaluation: Preclinical toxicology research is crucial for evaluating drug properties. The acute toxicity test showed that the LD50 value of sophocarpine was relatively high, indicating its low acute toxicity. Long term repeated administration toxicity testing requires a systematic evaluation of its potential effects on major organs (heart, liver, kidney, hematopoietic system, etc.). It is particularly noteworthy that it has no hERG inhibitory activity and low risk of Ames mutagenicity, providing preliminary guarantees for its cardiac safety and genetic toxicity. However, a comprehensive evaluation of reproductive toxicity, immunotoxicity, and other factors still needs to be completed.
Clinical application prospects and prospects
The transition of sophocarpine from laboratory to clinical practice has broad prospects but also presents challenges.
Clinical application potential:
1. New anti pancreatic cancer drugs: As a single drug or combined with gemcitabine, albumin binding paclitaxel and other existing standard therapies, it is expected to improve the therapeutic effect of pancreatic cancer and overcome drug resistance. Its good tolerance may improve the quality of life of patients.
2. Adjuvant treatment for lung cancer: For specific molecular subtypes of lung cancer (such as STAT3 sustained activation type), sophoridine can be used as a supplement to targeted therapy. Its multi-target properties also contribute to addressing tumor heterogeneity and adaptive drug resistance.
3. Combination therapy strategy: The combination with immune checkpoint inhibitors (such as PD-1/PD-L1 antibodies) is a highly attractive direction. Huaiding alkaloid may reverse the immunosuppressive state and enhance the efficacy of immunotherapy by inhibiting immune suppressive signals (such as NF - κ B and STAT3) in the tumor microenvironment.
4. Other disease areas: Its anti-inflammatory activity can be used to treat inflammatory diseases, and its regulatory effect on MAPT leaves room for exploration in the field of tau protein disease.
Challenges and future research directions:
1. Deep analysis of the mechanism of action: It is necessary to use chemical biology methods such as affinity fishing and molecular probes to more accurately identify its direct target proteins and draw a clearer pharmacological action network map.
2. Pharmacokinetic optimization: It is necessary to thoroughly elucidate the ADME (absorption, distribution, metabolism, excretion) process in the human body, and clarify the potential for key metabolic enzymes and drug interactions. The development and clinical translation of new delivery systems are crucial.
3. Clinical research advancement: At present, sophoridine has entered some early clinical trials (such as for advanced solid tumors), but it is necessary to design rigorous Phase I-III clinical trials, especially in indications such as pancreatic cancer, to confirm its effectiveness and safety.
4. Structural modification and derivative development: Reasonable structural modifications based on the core skeleton of sophocarpine aim to improve its activity, selectivity, water solubility, or pharmacokinetic properties, which is an important approach for discovering "me better" or even "first in class" new drugs.
Conclusion
Sophoridine, a natural quinoxaline alkaloid derived from the traditional Chinese medicine Sophora flavescens, has become a new star in the field of anti-tumor drug research and development due to its unique chemical structure, significant anti-tumor activity (especially for refractory pancreatic cancer), multi-target mechanism of action and relatively good early drug characteristics. It is not only a bridge connecting traditional medical wisdom with modern scientific research, but also a natural template for multi-target treatment strategies. Although there are still many challenges in comprehensively clarifying its molecular mechanism, optimizing its pharmacokinetic properties and promoting clinical transformation, with the continuous deepening of research and the application of new technologies and new strategies, sophoridine and its derivatives are very promising to develop into a new class of high efficiency and low toxicity anti-tumor drugs, bringing new treatment options and hope for patients with pancreatic cancer and other malignant tumors. The research process once again confirms the enormous value and vitality of searching for innovative drug lead compounds from natural products.
